| Discipline name | D-Index | World Ranking | Current World Ranking | National Ranking | Current National Ranking | Publications | Citations |
|---|---|---|---|---|---|---|---|
| Molecular Biology | 63 | 1784 | 1606 | 123 | 114 | 151 | 19653 |
The chart shows the history of publications by Michael Rehli between 1995 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michael Rehli published across 31 years, from 1995 to 2025, averaging 8.3 papers a year. Output peaked at 77 publications in 2023. 21 of the 258 publications appeared in the last two years.
258 publications in total across all disciplines
| Year | Publications |
|---|---|
| 1995 | 2 |
| 1996 | 4 |
| 1997 | 5 |
| 1998 | 2 |
| 1999 | 1 |
| 2000 | 3 |
| 2001 | 0 |
| 2002 | 10 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 6 |
| 2009 | 10 |
| 2010 | 13 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 11 |
| 2014 | 6 |
| 2015 | 9 |
| 2016 | 4 |
| 2017 | 12 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 77 |
| 2024 | 11 |
| 2025 | 10 |
| Total | 258 |
The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Michael Rehli sits on this spectrum.
This scientist: 151 publications — 38th percentile
38% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 564 publications or more.
| Publications | Scientists | This scientist |
|---|---|---|
| 47–56 | 7 | |
| 57–66 | 17 | |
| 67–76 | 65 | |
| 77–86 | 90 | |
| 87–96 | 125 | |
| 97–106 | 131 | |
| 107–116 | 162 | |
| 117–126 | 177 | |
| 127–136 | 158 | |
| 137–146 | 158 | |
| 147–156 | 146 | 151 |
| 157–166 | 159 | |
| 167–176 | 131 | |
| 177–186 | 110 | |
| 187–196 | 112 | |
| 197–206 | 100 | |
| 207–216 | 89 | |
| 217–226 | 98 | |
| 227–236 | 74 | |
| 237–246 | 72 | |
| 247–256 | 63 | |
| 257–266 | 53 | |
| 267–276 | 54 | |
| 277–286 | 49 | |
| 287–296 | 52 | |
| 297–306 | 43 | |
| 307–316 | 46 | |
| 317–326 | 41 | |
| 327–336 | 42 | |
| 337–346 | 31 | |
| 347–356 | 28 | |
| 357–366 | 29 | |
| 367–376 | 26 | |
| 377–386 | 24 | |
| 387–396 | 24 | |
| 397–406 | 14 | |
| 407–416 | 13 | |
| 417–426 | 20 | |
| 427–436 | 12 | |
| 437–446 | 20 | |
| 447–456 | 11 | |
| 457–466 | 10 | |
| 467–476 | 14 | |
| 477–486 | 14 | |
| 487–496 | 10 | |
| 497–506 | 13 | |
| 507–516 | 13 | |
| 517–526 | 2 | |
| 527–536 | 4 | |
| 537–546 | 6 | |
| 547–556 | 8 | |
| 557–563 | 6 | |
| 564+ | 100 |
The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Rehli sits on this spectrum.
This scientist: 63 D-Index — 43rd percentile
43% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 145 D-Index or more.
| D-Index | Scientists | This scientist |
|---|---|---|
| 40–41 | 36 | |
| 42–43 | 101 | |
| 44–45 | 115 | |
| 46–47 | 121 | |
| 48–49 | 118 | |
| 50–51 | 130 | |
| 52–53 | 106 | |
| 54–55 | 116 | |
| 56–57 | 113 | |
| 58–59 | 129 | |
| 60–61 | 120 | |
| 62–63 | 105 | 63 |
| 64–65 | 131 | |
| 66–67 | 95 | |
| 68–69 | 97 | |
| 70–71 | 106 | |
| 72–73 | 83 | |
| 74–75 | 89 | |
| 76–77 | 77 | |
| 78–79 | 70 | |
| 80–81 | 73 | |
| 82–83 | 60 | |
| 84–85 | 48 | |
| 86–87 | 45 | |
| 88–89 | 50 | |
| 90–91 | 31 | |
| 92–93 | 51 | |
| 94–95 | 43 | |
| 96–97 | 38 | |
| 98–99 | 39 | |
| 100–101 | 41 | |
| 102–103 | 29 | |
| 104–105 | 33 | |
| 106–107 | 35 | |
| 108–109 | 20 | |
| 110–111 | 38 | |
| 112–113 | 19 | |
| 114–115 | 28 | |
| 116–117 | 13 | |
| 118–119 | 23 | |
| 120–121 | 16 | |
| 122–123 | 15 | |
| 124–125 | 11 | |
| 126–127 | 21 | |
| 128–129 | 7 | |
| 130–131 | 13 | |
| 132–133 | 14 | |
| 134–135 | 17 | |
| 136–137 | 9 | |
| 138–139 | 8 | |
| 140–141 | 16 | |
| 142–143 | 7 | |
| 144 | 7 | |
| 145+ | 100 |
Michael Rehli is affiliated with the University of Regensburg in Germany. Their research primarily spans the fields of Immunology and Microbiology, Biochemistry, Genetics and Molecular Biology, and Medicine. Within these broader fields, their work focuses on subfields such as Immunology, Molecular Biology, Hematology, Genetics, and Oncology.
The scientist's research covers multiple main topics including Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Epigenetics and DNA Methylation, CAR-T cell therapy research, Genomics and Chromatin Dynamics, and Hematopoietic Stem Cell Transplantation.
Frequent collaborators in their research include Claudia Gebhard, Petra Hoffmann, Nicholas Strieder, Wolfgang Herr, and Christian Schmidl. These coauthors have contributed substantially to various projects alongside Michael Rehli.
Their frequent publication venues reflect the scope and impact of their research. These include Nature Communications, bioRxiv (Cold Spring Harbor Laboratory), Blood, Immunity, and Proceedings of the National Academy of Sciences.
Selected recent papers authored or co-authored by Michael Rehli include:
Robin Andersson;Claudia Gebhard;Irene Miguel-Escalada;Ilka Hoof
Alistair R.R. Forrest;Hideya Kawaji;Michael Rehli;J. Kenneth Baillie
Alexzander Asea;Michael Rehli;Edith Kabingu;Jason A. Boch
Marina Lizio;Jayson Harshbarger;Hisashi Shimoji;Jessica Severin
Derek De Rie;Imad Abugessaisa;Tanvir Alam;Erik Arner
Harukazu Suzuki;Alistair R.R. Forrest;Erik Van Nimwegen;Carsten O. Daub
Michael Rehli
M. Rehli;S. W. Krause;Reinhard Andreesen
Shuhei Noguchi;Takahiro Arakawa;Shiro Fukuda;Masaaki Furuno
E. Gottfried;L. A. Kunz-Schughart;A. Weber;M. Rehli
Christian Schmidl;Maja Klug;Tina J. Boeld;Reinhard Andreesen
Michael Rehli;Alexander Poltorak;Lucia Schwarzfischer;Stefan W. Krause
Daniel W. Mueller;Michael Rehli;Anja K. Bosserhoff
Maja Klug;Michael Rehli
Michael Rehli;Hans Helmut Niller;Christoph Ammon;Sabine Langmann
Sven Heinz;Viola Haehnel;Marina Karaghiosoff;Lucia Schwarzfischer
Stefan W. Krause;Michael Rehli;Marina Kreutz;Lucia Schwarzfischer
Claudia Gebhard;Lucia Schwarzfischer;Thu-Hang Pham;Elmar Schilling
Viola Haehnel;Lucia Schwarzfischer;Matthew J. Fenton;Michael Rehli
Christian Schmidl;Kathrin Renner;Katrin Peter;Ruediger Eder
If you think any of the details on this page are incorrect, let us know.
Exploring a career in Molecular Biology opens doors to a variety of healthcare and research professions. Many students consider related fields—such as nursing and advanced practice—where biological expertise is essential. If you’re interested in patient care or specialized nursing roles, it can be helpful to understand how many years to become a nurse practitioner. This pathway requires a solid foundation in biology as well as advanced clinical training.
For current registered nurses aiming to advance quickly, there are flexible options like rn to bsn online degree programs. These allow RNs to earn a Bachelor of Science in Nursing efficiently—an important step for many career advancements. Others may prefer transitioning from an associate degree; asn to np programs provide accelerated tracks leading directly from RN credentials to Nurse Practitioner status.
Non-nursing graduates with a background in molecular biology or other sciences can also pursue advanced degrees through direct entry msn programs. These intensive online programs enable students from diverse educational backgrounds to enter the nursing field and specialize in roles that blend biological sciences with patient care.
Karlsruhe Institute of Technology
Chinese Academy of Sciences
Simon Fraser University
Tokyo Medical and Dental University
Natural Environment Research Council
Arizona State University
Charles Sturt University
Gwangju Institute of Science and Technology
University of Rochester
Copenhagen Business School
Université Laval
Boston Children's Hospital
Harvard University
University of Montreal
University of Sydney
University of Tübingen
